Literature DB >> 6517932

Inhibition of lipid peroxidation by a novel compound (CV-2619) in brain mitochondria and mode of action of the inhibition.

M Suno, A Nagaoka.   

Abstract

Lipid peroxidation in rat brain mitochondria was induced by NADH in the presence of ADP and FeCl3. CV-2619 inhibited the lipid peroxidation in a concentration-dependent manner; the concentration giving 50% inhibition (IC50) was 84 microM. In addition, the inhibitory effect of CV-2619 was strongly enhanced by adding substrates of mitochondrial respiration; when succinate, glutamate, or succinate plus glutamate was added, the IC50 of CV-2619 was changed to 1.1, 10, or 0.5 microM, respectively. Metabolites of CV-2619 also inhibited the lipid peroxidation. The inhibitory effect of CV-2619 on mitochondrial lipid peroxidation disappeared when TTFA, an inhibitor of complex II in mitochondrial respiratory chain, was added. The results indicate that in mitochondria CV-2619 is changed to its reduced form which inhibits lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6517932     DOI: 10.1016/0006-291x(84)91389-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Friedreich ataxia-update on pathogenesis and possible therapies.

Authors:  Max Voncken; Panos Ioannou; Martin B Delatycki
Journal:  Neurogenetics       Date:  2003-12-19       Impact factor: 2.660

2.  Idebenone inhibition of glutamate release from rat cerebral cortex nerve endings by suppression of voltage-dependent calcium influx and protein kinase A.

Authors:  Yi Chang; Yu-Wan Lin; Su-Jane Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-04       Impact factor: 3.000

Review 3.  Idebenone: an emerging therapy for Friedreich ataxia.

Authors:  Thomas Meier; Gunnar Buyse
Journal:  J Neurol       Date:  2009-03       Impact factor: 4.849

Review 4.  Evolution of cytochrome bc complexes: from membrane-anchored dehydrogenases of ancient bacteria to triggers of apoptosis in vertebrates.

Authors:  Daria V Dibrova; Dmitry A Cherepanov; Michael Y Galperin; Vladimir P Skulachev; Armen Y Mulkidjanian
Journal:  Biochim Biophys Acta       Date:  2013-07-19

5.  Inhibitory effects of calcium antagonists on mitochondrial swelling induced by lipid peroxidation or arachidonic acid in the rat brain in vitro.

Authors:  M Takei; M Hiramatsu; A Mori
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

Review 6.  Neuropathobiology of senile dementia and mechanism of action of nootropic drugs.

Authors:  O Benesová
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

7.  The tumor suppressor cybL, a component of the respiratory chain, mediates apoptosis induction.

Authors:  Timur Albayrak; Volker Scherhammer; Nicole Schoenfeld; Erik Braziulis; Thomas Mund; Manuel K A Bauer; Immo E Scheffler; Stefan Grimm
Journal:  Mol Biol Cell       Date:  2003-05-18       Impact factor: 4.138

Review 8.  Idebenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders.

Authors:  J C Gillis; P Benefield; D McTavish
Journal:  Drugs Aging       Date:  1994-08       Impact factor: 3.923

Review 9.  Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier?

Authors:  Sausan Jaber; Brian M Polster
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

10.  Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy.

Authors:  Fabrice D Heitz; Michael Erb; Corinne Anklin; Dimitri Robay; Vincent Pernet; Nuri Gueven
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.